Your browser doesn't support javascript.
loading
Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases.
Schreiber, Karen; Giles, Ian; Costedoat-Chalumeau, Nathalie; Nelson-Piercy, Catherine; Dolhain, Radboud Jem; Mosca, Marta; Förger, Frauke; Fischer-Betz, Rebecca; Molto, Anna; Tincani, Angela; Pasquier, Elisabeth; Marin, Benoit; Elefant, Elisabeth; Salmon, Jane; Bermas, Bonnie L; Sammaritano, Lisa; Clowse, Megan E B; Chambers, Christina; Buyon, Jill; Inoue, Saori Abe; Agmon-Levin, Nancy; Aguilera, Silvia; Emadi, Samar Al; Andersen, Jeanette; Andrade, Danieli; Antovic, Aleksandra; Arnaud, Laurent; Christiansen, Alice Ashouri; Avcin, Tadej; Badreh-Wirström, Sara; Bertsias, George; Bini, Ilaria; Bobirca, Anca; Branch, Ware; Brucato, Antonio; Bultink, Irene; Capela, Susanna; Cecchi, Irene; Cervera, Ricard; Chighizola, Cecilia; Cobilinschi, Claudia; Cuadrado, Maria Jose; Dey, Dzifa; Etomi, Oseme; Espinosa, Gerard; Flint, Julia; Fonseca, João-Eurico; Fritsch-Stork, Ruth; Gerosa, Maria; Glintborg, Bente.
Afiliación
  • Schreiber K; Danish Centre for Expertise in Rheumatology (CeViG), Danish Hospital for Rheumatic Diseases, Sonderborg, Denmark (KS); Institute for Regional Health, Southern Danish University, Odense, Denmark. Electronic address: kschreiber@danskgigthospital.dk.
  • Giles I; Centre for Rheumatology, UCL Division of Medicine, London, UK.
  • Costedoat-Chalumeau N; AP-HP, Hôpital Cochin, Centre de Référence Maladies Auto-Immunes et Systémiques Rares, Paris, France; Université Paris Cité, Paris, France.
  • Nelson-Piercy C; Department of Obstetric Medicine, Guy's and St Thomas' NHS Foundation Trust, London, UK (CN-P, OE).
  • Dolhain RJ; Erasmus MC, University Medical Centre, Department of Rheumatology, Rotterdam, Netherlands.
  • Mosca M; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Förger F; Department of Rheumatology, Immunology and Allergology, University Hospital of Bern, Bern, Switzerland.
  • Fischer-Betz R; Department for Rheumatology and Hiller Research Institute, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Molto A; Rheumatology Department, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France; INSERM (U1153), PRES Sorbonne Paris-Cité, Paris, France.
  • Tincani A; Rheumatology and Clinical Immunology Unit, ASST-Spedali Civili and University, Brescia, Italy.
  • Pasquier E; Département de Médecine Interne et Pneumologie, CHRU de Brest, Hôpital de la Cavale Blanche, Brest, France; INSERM, Centre d'Investigation Clinique 1412, CHRU de Brest, Brest, France.
  • Marin B; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital Trousseau, Département de Santé Publique, Centre de Référence sur les Agents Tératogènes, F75012, Paris, France.
  • Elefant E; AP-HP, Sorbonne Université, Hôpital Trousseau, Département de Santé Publique, Centre de Référence sur les Agents Tératogènes, F75012, Paris, France.
  • Salmon J; Weill Cornell Medicine, Hospital for Special Surgery, New York, New York, USA.
  • Bermas BL; UT Southwestern Medical Center, Dallas, Texas, USA.
  • Sammaritano L; Weill Cornell Medicine, Hospital for Special Surgery, New York, New York, USA.
  • Clowse MEB; Division of Rheumatology and Immunology, Duke University School of Medicine, Durham, North Carolina, USA.
  • Chambers C; Department of Paediatrics, University of California, San Diego, La Jolla, CA, USA.
  • Buyon J; Division of Rheumatology, New York University Grossman School of Medicine, New York, NY, USA.
  • Inoue SA; Department of Rheumatology, Institute of Medicine, University of Tsukuba, Japan.
  • Agmon-Levin N; The Zabludowicz Centre for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel; The Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Aguilera S; Spanish Antiphospholipid Syndrome Association, Elche, Spain.
  • Emadi SA; Rheumatology, Hamad Medical Corporation, Doha, Qatar.
  • Andersen J; Lupus Europe, Copenhagen, Denmark.
  • Andrade D; Rheumatology, University of Sao Paulo, Sao Paulo, Sao Paulo, Brazil.
  • Antovic A; Department of Medicine, Division of Rheumatology Karolinska Institutet and Rheumatology, Karolinska University Hospital Stockholm, Sweden.
  • Arnaud L; Service de Rhumatologie, Hôpitaux Universitaires de Strasbourg, Centre National de Références Maladies Auto-Immunes, Strasbourg, France.
  • Christiansen AA; Danish Center for Expertise in Rheumatology, Danish Hospital for Rheumatic Diseases, Sønderborg, Denmark.
  • Avcin T; Department of Allergology, Rheumatology and Clinical Immunology, University Children's Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia.
  • Badreh-Wirström S; Senior European and Regulatory Affairs Project Manager, EULAR PARE, Brussels, Belgium.
  • Bertsias G; Rheumatology, University of Crete School of Medicine, Iraklio, Greece; Laboratory of Autoimmunity-Inflammation, Institute of Molecular Biology and Biotechnology, Heraklion, Greece.
  • Bini I; EULAR YOUNG PARE, Avellino, Italy.
  • Bobirca A; Department of Internal Medicine and Rheumatology, Dr I Cantacuzino Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Branch W; Department of Obstetrics and Gynecology, University of Utah School of Medicine, Salt Lake City, UT, USA.
  • Brucato A; Department of Biomedical and Clinical Sciences, University of Milano, Fatebenefratelli Hospital, Milano, Italy.
  • Bultink I; Department of Rheumatology, Amsterdam Rheumatology and immunology Centre, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
  • Capela S; Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte EPE, Faculty of Medicine, University of Lisbon, Lisbon Academic Medical Centre, Lisbon, Portugal.
  • Cecchi I; Centre of Research of Immunopathology and Rare Diseases, Department of Clinical and Biological Sciences, University of Turin, San Giovanni Hospital, Turin, Italy.
  • Cervera R; Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, Barcelona, Spain.
  • Chighizola C; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy; Paediatric Rheumatology Unit, ASST Pini, CTO, Milan, Italy.
  • Cobilinschi C; Department of Internal Medicine and Rheumatology Sânta Maria Clinical Hospital, Bucharest, Romania; Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Cuadrado MJ; Rheumatology Department, Clinica Universidad de Navarra, Madrid, Spain.
  • Dey D; Rheumatology Unit, Department of Medicine and Therapeutics, Korle Bu Teaching Hospital, University of Ghana Medical School, Accra, Ghana.
  • Etomi O; Department of Obstetric Medicine, Guy's and St Thomas' NHS Foundation Trust, London, UK (CN-P, OE).
  • Espinosa G; Department of Autoimmune Diseases, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi I Sunyer, University of Barcelona, Barcelona, Spain.
  • Flint J; Department of Rheumatology, Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust, Oswestry, UK.
  • Fonseca JE; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa and Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.
  • Fritsch-Stork R; Health Care Centre Mariahilf, ÖGK and Rheumatology Department at the Sigmund Freud Private University, Vienna, Austria.
  • Gerosa M; Department of Clinical Sciences and Community Health, Research Centre for Adult and Paediatric Rheumatic Diseases, University of Milan, Milan, Italy; Clinical Rheumatology Unit, ASST G Pini and CTO, Milan, Italy.
  • Glintborg B; DANBIO and Copenhagen Centre for Arthritis Research, Centre for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Copenhagen University Hospital, Rigshospitalet, Glostrup, Denmark.
Lancet Rheumatol ; 5(9): e501-e506, 2023 Sep.
Article en En | MEDLINE | ID: mdl-38251494

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Hidroxicloroquina Límite: Female / Humans / Pregnancy Idioma: En Revista: Lancet Rheumatol Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Hidroxicloroquina Límite: Female / Humans / Pregnancy Idioma: En Revista: Lancet Rheumatol Año: 2023 Tipo del documento: Article